193 related articles for article (PubMed ID: 7590237)
1. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.
Shi Y; Alin K; Goff SP
Genes Dev; 1995 Nov; 9(21):2583-97. PubMed ID: 7590237
[TBL] [Abstract][Full Text] [Related]
2. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.
Dai Z; Pendergast AM
Genes Dev; 1995 Nov; 9(21):2569-82. PubMed ID: 7590236
[TBL] [Abstract][Full Text] [Related]
3. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).
Taki T; Shibuya N; Taniwaki M; Hanada R; Morishita K; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1998 Aug; 92(4):1125-30. PubMed ID: 9694699
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of v-Abl transformation in 3T3 cells overexpressing different forms of the Abelson interactor protein Abi-1.
Ikeguchi A; Yang HY; Gao G; Goff SP
Oncogene; 2001 Aug; 20(36):4926-34. PubMed ID: 11526477
[TBL] [Abstract][Full Text] [Related]
5. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
Warren D; Heilpern AJ; Berg K; Rosenberg N
J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
[TBL] [Abstract][Full Text] [Related]
6. Abl interactor 1 binds to sos and inhibits epidermal growth factor- and v-Abl-induced activation of extracellular signal-regulated kinases.
Fan PD; Goff SP
Mol Cell Biol; 2000 Oct; 20(20):7591-601. PubMed ID: 11003655
[TBL] [Abstract][Full Text] [Related]
7. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL; Hoffmann FM
Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel member of the DOK family that binds and modulates Abl signaling.
Cong F; Yuan B; Goff SP
Mol Cell Biol; 1999 Dec; 19(12):8314-25. PubMed ID: 10567556
[TBL] [Abstract][Full Text] [Related]
9. ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks.
Wang B; Golemis EA; Kruh GD
J Biol Chem; 1997 Jul; 272(28):17542-50. PubMed ID: 9211900
[TBL] [Abstract][Full Text] [Related]
10. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
Fan PD; Cong F; Goff SP
Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
[TBL] [Abstract][Full Text] [Related]
11. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
Warren D; Griffin DS; Mainville C; Rosenberg N
J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
[TBL] [Abstract][Full Text] [Related]
12. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
[TBL] [Abstract][Full Text] [Related]
13. Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase.
Tani K; Sato S; Sukezane T; Kojima H; Hirose H; Hanafusa H; Shishido T
J Biol Chem; 2003 Jun; 278(24):21685-92. PubMed ID: 12672821
[TBL] [Abstract][Full Text] [Related]
14. Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton.
Ziemnicka-Kotula D; Xu J; Gu H; Potempska A; Kim KS; Jenkins EC; Trenkner E; Kotula L
J Biol Chem; 1998 May; 273(22):13681-92. PubMed ID: 9593709
[TBL] [Abstract][Full Text] [Related]
15. Salpalpha and Salpbeta, growth-arresting homologs of Sam68.
Lee J; Burr JG
Gene; 1999 Nov; 240(1):133-47. PubMed ID: 10564820
[TBL] [Abstract][Full Text] [Related]
16. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren R; Ye ZS; Baltimore D
Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
18. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
Jackson PK; Paskind M; Baltimore D
Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
[TBL] [Abstract][Full Text] [Related]
19. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity.
Wen ST; Van Etten RA
Genes Dev; 1997 Oct; 11(19):2456-67. PubMed ID: 9334312
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
